Therapix expects to have results of Tourette's drug trial by end of Q1 [Reuters]
THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE (TRPX)
US:NASDAQ Investor Relations:
nasdaq.com/symbol/trpx
Company Research
Source: Reuters
Therapix expects to have results of Tourette's drug trial by end of Q1 | Reuters 3 Min Read TEL AVIV, Dec 4 (Reuters) - Israel’s Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette’s syndrome which could be worth billions of dollars in revenues. It has completed enrolment of 16 patients for its Phase IIa study at Yale University, where it will assess the drug that combines a synthetic cannabinoid already approved by the U.S. Food and Drug Administration with a fatty acid derivative called palmitoylethanolamide (PEA). Therapix believes PEA may increase the efficacy of the cannabinoid while lowering the required dosage and reducing adverse effects. Subjects in the 12-week study will receive a once-daily oral treatment with the objective of proving its safety, tolerability and efficacy in treating tics in adults with Tourette‘s, a neurological disorder characterised by repetitive
Show less
Read more
Impact Snapshot
Event Time:
TRPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRPX alerts
High impacting THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE news events
Weekly update
A roundup of the hottest topics